1 documents found
Information × Registration Number 0114U006327, R & D request Title 52-week, double-blind, randomized, placebo-controlled study in parallel groups to assess the impact roflumirastu at a dose of 500 mg on the frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD), which is treated Raman beta-agonist and long-acting inhaled corticosteroid (BATD / ILS) at a fixed dose of Head Кайдашев Ігор Петрович, Registration Date 02-10-2014 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
52-week, double-blind, randomized, placebo-controlled study in parallel groups to assess the impact roflumirastu at a dose of 500 mg on the frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD), which is treated Raman beta-agonist and long-acting inhaled corticosteroid (BATD / ILS) at a fixed dose of
Head: Кайдашев Ігор Петрович. 52-week, double-blind, randomized, placebo-controlled study in parallel groups to assess the impact roflumirastu at a dose of 500 mg on the frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD), which is treated Raman beta-agonist and long-acting inhaled corticosteroid (BATD / ILS) at a fixed dose of. Ukrainian medical stomatological Academy. № 0114U006327
1 documents found

Updated: 2026-03-21


Роздрукувати цю сторінку